Principal, Clinical Product (Fully Remote)

Headway; United States; Remote; USD 150.000 - 190.000; Vollzeit

Zusammenfassung

Headway, a Series D healthtech company, seeks a licensed psychiatrist or psychologist to lead clinical governance for AI-enabled mental health tools. You will partner with product, design, engineering, and data teams to ensure clinical soundness and patient safety across features.

From problem definition to launch, you will translate clinical workflows into engineering requirements and define measurable quality standards. This is a full-time on-site role dedicated to improving access to therapy.

Qualifikationen

• Licensed psychiatrist or psychologist with 6+ years of experience.
• Strong background in AI governance and healthcare tools.
• Ability to translate clinical workflows into engineering requirements.

Aufgaben

• Embed clinical expertise into product design and governance.
• Ensure clinically sound, AI-enabled features.
• Collaborate with product, design, engineering, and data teams.
• Shape clinical input from problem definition to launch.
• Translate workflows into requirements for engineers and designers.
• Define measurable clinical quality and safety standards.

Kenntnisse

Licensed psychiatrist or psychologist

AI governance

Healthcare tools

Ausbildung

Medical degree in Psychiatry or Psychology with license

Jobbeschreibung

• Embed clinical expertise into product design and governance.
• Ensure clinically sound, ethical, AI-enabled features.
• Collaborate with product, design, engineering, and data teams.

What You'll Do:

• Shape clinical input from problem definition to launch.
• Translate workflows into requirements for engineers and designers.
• Define measurable clinical quality and safety standards.

Who You Are:

• Licensed psychiatrist or psychologist with 6+ years experience.
• Strong background in AI governance and healthcare tools.

Headway

Headway builds software that helps mental health providers accept insurance and run their practices, improving access to therapy. It is a Series D company backed by top investors, with over 85,000 providers and 1 million patients served.